Physician profile
Anthony Duany
NPI 1790716975
$4,792.62
in general payments reported to CMS, 2019-2025
34 companies · $698 in 2025
The $698 reported for 2025 was more than what 79% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $695 · 2020: $1,111 · 2021: $465 · 2022: $910 · 2023: $529 · 2024: $384 · 2025: $698.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $829.58 | 2019-2025 | Airsupra, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $590.63 | 2021-2025 | |
| Lilly USA, LLC | $562.61 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbvie INC. | $399.07 | 2019-2023 | Rinvoq |
| Novo Nordisk INC | $354.80 | 2019-2024 | Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $249.89 | 2019-2022 | |
| Renalytix Ai, INC. | $247.28 | 2024-2025 | Kidneyintelx Blood Collection Convenience Kit |
| Amarin Pharma, INC. | $187.18 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $162.46 | 2019-2024 | Synjardy, Jardiance |
| Glaxosmithkline, LLC. | $137.80 | 2020 | |
| Exact Sciences Corporation | $130.08 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $113.55 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $111.86 | 2022 | |
| Gilead Sciences, INC. | $89.60 | 2019-2025 | |
| Horizon Therapeutics Plc | $86.72 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $63.06 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $56.85 | 2019-2021 | |
| Vanda Pharmaceuticals INC. | $49.72 | 2022 | |
| Endo Pharmaceuticals INC. | $45.97 | 2020 | |
| Angiodynamics, INC. | $40.98 | 2025 | Auryon Laser System 100-120 Vac |
| Merck Sharp & Dohme LLC | $36.05 | 2020 | |
| Amgen INC. | $31.41 | 2019-2020 | |
| Medtronic Vascular, INC. | $27.98 | 2019 | |
| Nevro Corp. | $25.06 | 2019 | |
| Astellas Pharma US INC | $21.55 | 2021 | |
| Allergan, INC. | $20.16 | 2020 | |
| Alk-Abello, INC | $18.36 | 2024 | Odactra, Ragwitek, Grastek |
| Vivus LLC | $17.53 | 2022 | |
| Dexcom, INC. | $17.28 | 2021 | |
| Novartis Pharmaceuticals Corporation | $16.16 | 2022 | |
| Sun Pharmaceutical Industries INC. | $14.43 | 2020 | |
| Janssen Pharmaceuticals, INC | $13.41 | 2019 | |
| Idorsia Pharmaceuticals US INC | $12.71 | 2023 | Quviviq |
| Supernus Pharmaceuticals, INC. | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Duany listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.